WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
SynBioBeta 2025: The Global Synthetic Biology Conference
Affiliated Programs
Monday, May 5, 2025 - Thursday, May 8, 2025

San Jose Convention Center
San Jose, CA

Wilson Sonsini is proud to sponsor SynBioBeta 2025: The Global Synthetic Biology Conference, where biology becomes the blueprint and human innovation, the artisan. Attend this event for an unparalleled four-day summit delving into synthetic biology.

On Tuesday, May 6th at 4:30 pm partner Ian Edvalson will moderate the panel session, Future of the U.S. Bioeconomy, with panelists Carrie Wolinetz, Government Relations at Lewis-Burke Associates LLC; Sarah Carter, Principal at Science Policy Consulting; Kerri Dugan from TIP Emerging Technologies, at the National Science Foundation; and Sylvia Wulf, Interim EVP at Biotechnology Innovation Organization (BIO).

On Thursday, May 8th at 1:30 pm partner Maya Skubatch will moderate the panel session, SynBio Solutions: Fast-Tracking Vaccines and Personalized Medicine for Global Health, with panelists Jacob Glanville, Founder, CEO & Chairman of Centivax; Brian Parker, Head of Bioinformatics at BreakBio; Maurizio Zanetti, UCSD Cancer Center; Clare Lou, CEO & Co-Founder at Sift Biosciences; and Bernie Fox, Co-Founder and CEO of UbiVac.

On Thursday, May 8th at 2:30 pm partner Maya Skubatch will moderate the panel session, Deconstructing Cellular Diversity: Single-Cell Sequencing for Drug Discovery and Synthetic Biology. Fellow panelists include Alex Rosenberg, CEO at Parse Biosciences; Rob Tarbox, VP of Product Marketing at Complete Genomics; Xi Chen, Founder of RootPath Genomics, and Nima Alidoust, CEO & Co-Founder, at Vevo Therapeutics.

At the conference, learn why the costs of reading, writing, and editing DNA plummet while speed and accessibility soar. Gain insights into cutting-edge medical advancements such as cell therapies, vaccines, and living medicines. Discover how companies harness biology to produce bio-based jet fuel, textiles, concrete, and other chemicals and materials. Engage with trailblazing entrepreneurs crafting innovative foods, crops, and fragrances. Join us to see the potential applications of these technologies in shaping sustainable manufacturing ecosystems.

Contacts

Katie Stonum

kstonum@wsgr.com

Presenters

Ian B. Edvalson
Partner
Palo Alto

Ian advises life sciences clients in strategic alliances, agreements, arrangements, collaborations, and joint ventures.

View Profile
Maya Skubatch
Partner
Palo Alto

Maya focuses on strategic patent counseling for healthcare and other technology-driven companies.

View Profile
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.